Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Buy
1,229
+274
+29% +$115K 0.04% 481
2026
Q1
$361K Buy
955
+8
+0.8% +$3.43K 0.03% 633
2025
Q4
$405K Sell
947
-4
-0.4% -$1.74K 0.03% 577
2025
Q3
$426K Buy
951
+117
+14% +$53K 0.03% 556
2025
Q2
$406K Hold
834
0.03% 569
2025
Q1
$513K Buy
+834
New +$474K 0.04% 445
2024
Q4
Sell
-671
Closed -$403K 1395
2024
Q3
$403K Buy
671
+119
+22% +$67.5K 0.03% 543
2024
Q2
$299K Buy
552
+197
+55% +$113K 0.03% 613
2024
Q1
$227K Sell
355
-104
-23% -$63.2K 0.02% 694
2023
Q4
$268K Sell
459
-9
-2% -$5.04K 0.03% 629
2023
Q3
$243K Buy
+468
New +$243K 0.03% 618

Other funds holding CHE

NBC Securities's CHE Position: Q2 2026 in Review

NBC Securities increased its Chemed (CHE) stake by 29% in Q2 2026, buying an estimated $115K and bringing the position to 1,229 shares worth $572K. The position accounts for 0.04% of the portfolio, ranked #481.

NBC Securities first reported a position in CHE in Q3 2023 and has held it in 11 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • NBC Securities held 1,229 shares of Chemed worth $572K as of Q2 2026.
  • NBC Securities bought 274 Chemed shares in Q2 2026, an estimated $115K.
  • Chemed made up 0.04% of NBC Securities's portfolio in Q2 2026, its #481 holding.
  • NBC Securities first reported a position in Chemed in Q3 2023 and has held it in 11 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.